Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $37.59M in the quarter ending June 30, 2026, with 98.59% growth. This brings the company's revenue in the last twelve months to $105.60M, up 81.49% year-over-year. In the year 2025, Eton Pharmaceuticals had annual revenue of $79.95M with 104.94% growth.

• Revenue (ttm): $105.60M
• Revenue Growth: +81.49%
• P/S Ratio: 16.64
• Revenue / Employee: $2,399,886
• Employees: 44
• Market Cap: 1.76B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	79.95M	40.94M	104.94%
Dec 31, 2024	39.01M	7.37M	23.29%
Dec 31, 2023	31.64M	10.39M	48.90%
Dec 31, 2022	21.25M	-581.00K	-2.66%
Dec 31, 2021	21.83M	21.79M	55,879.49%
Dec 31, 2020	39.00K	-920.00K	-95.93%
Dec 31, 2019	959.00K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-

Data Source: Fiscal.ai Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error